508 related articles for article (PubMed ID: 31044187)
1. Heterotopic Ossification: A Comprehensive Review.
Meyers C; Lisiecki J; Miller S; Levin A; Fayad L; Ding C; Sono T; McCarthy E; Levi B; James AW
JBMR Plus; 2019 Apr; 3(4):e10172. PubMed ID: 31044187
[TBL] [Abstract][Full Text] [Related]
2. Flare-Up After Maxillofacial Surgery in a Patient With Fibrodysplasia Ossificans Progressiva: An [
Eekhoff EMW; Netelenbos JC; de Graaf P; Hoebink M; Bravenboer N; Micha D; Pals G; de Vries TJ; Lammertsma AA; Raijmakers PG; van Es RJ
JBMR Plus; 2018 Jan; 2(1):55-58. PubMed ID: 30283890
[TBL] [Abstract][Full Text] [Related]
3. Palovarotene Action Against Heterotopic Ossification Includes a Reduction of Local Participating Activin A-Expressing Cell Populations.
Mundy C; Yao L; Shaughnessy KA; Saunders C; Shore EM; Koyama E; Pacifici M
JBMR Plus; 2023 Dec; 7(12):e10821. PubMed ID: 38130748
[TBL] [Abstract][Full Text] [Related]
4. The Expansion of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva Is Activin A-Dependent.
Upadhyay J; Xie L; Huang L; Das N; Stewart RC; Lyon MC; Palmer K; Rajamani S; Graul C; Lobo M; Wellman TJ; Soares EJ; Silva MD; Hesterman J; Wang L; Wen X; Qian X; Nannuru K; Idone V; Murphy AJ; Economides AN; Hatsell SJ
J Bone Miner Res; 2017 Dec; 32(12):2489-2499. PubMed ID: 28782882
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem-cell contribution to ectopic skeletogenesis.
Kaplan FS; Glaser DL; Shore EM; Pignolo RJ; Xu M; Zhang Y; Senitzer D; Forman SJ; Emerson SG
J Bone Joint Surg Am; 2007 Feb; 89(2):347-57. PubMed ID: 17272450
[TBL] [Abstract][Full Text] [Related]
6. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM
J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819
[TBL] [Abstract][Full Text] [Related]
7. Genetic and Acquired Heterotopic Ossification: A Translational Tale of Mice and Men.
Cappato S; Gamberale R; Bocciardi R; Brunelli S
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33327623
[TBL] [Abstract][Full Text] [Related]
8. Myositis ossificans in children: a review.
Sferopoulos NK; Kotakidou R; Petropoulos AS
Eur J Orthop Surg Traumatol; 2017 May; 27(4):491-502. PubMed ID: 28275867
[TBL] [Abstract][Full Text] [Related]
9. Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva.
Chakkalakal SA; Shore EM
Methods Mol Biol; 2019; 1891():247-255. PubMed ID: 30414138
[TBL] [Abstract][Full Text] [Related]
10. Analog Method for Radiographic Assessment of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva.
Rajapakse CS; Lindborg C; Wang H; Newman BT; Kobe EA; Chang G; Shore EM; Kaplan FS; Pignolo RJ
Acad Radiol; 2017 Mar; 24(3):321-327. PubMed ID: 27989444
[TBL] [Abstract][Full Text] [Related]
11. Vascular patterning in human heterotopic ossification.
Cocks M; Mohan A; Meyers CA; Ding C; Levi B; McCarthy E; James AW
Hum Pathol; 2017 May; 63():165-170. PubMed ID: 28315426
[TBL] [Abstract][Full Text] [Related]
12. Natural development of dermal ectopic bone in the american alligator (Alligator mississippiensis) resembles heterotopic ossification disorders in humans.
Dubansky BH; Dubansky BD
Anat Rec (Hoboken); 2018 Jan; 301(1):56-76. PubMed ID: 28837758
[TBL] [Abstract][Full Text] [Related]
13. BMP-dependent, injury-induced stem cell niche as a mechanism of heterotopic ossification.
Kan C; Ding N; Yang J; Tan Z; McGuire TL; Lu H; Zhang K; Berger DMP; Kessler JA; Kan L
Stem Cell Res Ther; 2019 Jan; 10(1):14. PubMed ID: 30635039
[TBL] [Abstract][Full Text] [Related]
14. Fibrodysplasia ossificans progressiva: a current review of imaging findings.
Bauer AH; Bonham J; Gutierrez L; Hsiao EC; Motamedi D
Skeletal Radiol; 2018 Aug; 47(8):1043-1050. PubMed ID: 29445932
[TBL] [Abstract][Full Text] [Related]
15. Elevated plasma RANTES in fibrodysplasia ossificans progressiva - A novel therapeutic target?
Grgurević L; Novak R; Trkulja V; Hamzić LF; Hrkač S; Grazio S; Santini M
Med Hypotheses; 2019 Oct; 131():109313. PubMed ID: 31443758
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of Magnetic Resonance Imaging in Fibrodysplasia Ossificans Progressiva.
Botman E; Teunissen BP; Raijmakers P; de Graaf P; Yaqub M; Treurniet S; Schoenmaker T; Bravenboer N; Micha D; Pals G; Bökenkamp A; Netelenbos JC; Lammertsma AA; Eekhoff EM
JBMR Plus; 2020 Jun; 4(6):e10363. PubMed ID: 32537549
[TBL] [Abstract][Full Text] [Related]
17. Fibrodysplasia ossificans progressiva: middle-age onset of heterotopic ossification from a unique missense mutation (c.974G>C, p.G325A) in ACVR1.
Whyte MP; Wenkert D; Demertzis JL; DiCarlo EF; Westenberg E; Mumm S
J Bone Miner Res; 2012 Mar; 27(3):729-37. PubMed ID: 22131272
[TBL] [Abstract][Full Text] [Related]
18. BMP and mTOR signaling in heterotopic ossification: Does their crosstalk provide therapeutic opportunities?
Wu J; Ren B; Shi F; Hua P; Lin H
J Cell Biochem; 2019 Aug; 120(8):12108-12122. PubMed ID: 30989716
[TBL] [Abstract][Full Text] [Related]
19. Sustained local ionic homeostatic imbalance caused by calcification modulates inflammation to trigger heterotopic ossification.
Bohner M; Maazouz Y; Ginebra MP; Habibovic P; Schoenecker JG; Seeherman H; van den Beucken JJJP; Witte F
Acta Biomater; 2022 Jun; 145():1-24. PubMed ID: 35398267
[TBL] [Abstract][Full Text] [Related]
20. Imaging assessment of fibrodysplasia ossificans progressiva: Qualitative, quantitative and questionable.
Al Mukaddam M; Rajapakse CS; Pignolo RJ; Kaplan FS; Smith SE
Bone; 2018 Apr; 109():147-152. PubMed ID: 28822792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
